I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 12 studies | 25% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 9 studies | 22% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 26% ± 6% | |
| gamma-delta T cell | 6 studies | 21% ± 6% | |
| CD8-positive, alpha-beta T cell | 5 studies | 22% ± 3% | |
| mature NK T cell | 4 studies | 19% ± 1% | |
| non-classical monocyte | 4 studies | 21% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 21% ± 5% | |
| B cell | 3 studies | 19% ± 4% | |
| classical monocyte | 3 studies | 21% ± 3% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 22% ± 6% | |
| memory B cell | 3 studies | 19% ± 2% | |
| mucosal invariant T cell | 3 studies | 22% ± 1% | |
| epithelial cell | 3 studies | 35% ± 15% | |
| dendritic cell | 3 studies | 25% ± 7% | |
| mast cell | 3 studies | 18% ± 3% |
